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SHORT COMMUNICATION
Aspergillus nidulans is a common soil saprophyte with a 
worldwide distribution. It was first isolated and described 
in 1906 by Nicolle & Pinoy in a Tunisian patient with 
mycetoma. Since then, only 4 cases of mycetoma have 
been published (1–5). We describe here a case of A. nidu-
lans mycetoma in which, for the first time, mycological 
and histopathological examinations were confirmed by 
molecular identification.
CASE REPORT
A 59-year-old man, from Senegal, was admitted to the Depart-
ment of Pathophysiology and Transplantation of the University of 
Milan, Italy, in September 2012 because of a giant nodular lesion 
on the left ankle and dorsum of the foot. His medical history 
revealed type I diabetes (diagnosed in 1996), peripheral diabetic 
neuropathy, amputation of the 2nd, 3rd, 4th and 5th left toes because 
of peripheral arterial occlusive disease and/or osteomyelitis (in 
2007), amputation of the 1st left toe because of osteomyelitis of 
the metatarsal head (in 2010), and bilateral proliferating diabetic 
retinopathy treated with argon laser (in 2012). At admission, no 
medication other than insulin was used by the patient. 
The patient reported that the nodular lesion had appeared in 
1996. A biopsy had been made at another centre with a diag-
nosis of eumycetoma, although no fungi were observed either 
by histopathological or mycological examination. The patient 
had been treated, although unsuccessfully, with oral terbinafine 
(unknown daily dosage and duration of therapy). From 1996, 
the patient had been followed up at different centres in Italy 
and Senegal. In August 2011, several sinuses appeared with 
purulent and bloody discharge. In October 2011, therapy with 
oral itraconazole (200 mg/day) was started. In September 2012, 
the patient was admitted to our department. Dermatological 
examination revealed a nodular lesion, approximately 13 cm 
long, on the left ankle and dorsum of the foot. The lesion 
contained several sinuses, from which a discharge of pus and 
blood was visible (Fig. 1). The consistency of the lesion was 
parenchymatous-hard. The patient reported experiencing pain. 
Laboratory examination revealed hyperglycaemia. X-rays of 
the left leg, ankle and foot showed several areas of osteoporosis.
A new biopsy was performed. Histopathological examination 
revealed hyperplasia of the epidermis and a dermal infiltrate. 
The latter was made up of histiocytes, neutrophils and plasma 
cells, surrounding some polylobated eosinophilic structures, 
filled with mycelial hyphae and spores (Fig. S11). A fragment 
of skin biopsy was cultured on brain heart infusion agar plus 
5% sheep blood, Sabouraud-dextrose agar (SDA) and Tryptone 
Soya Broth (Oxoid Limited, Basingstoke, UK) . Wrinkled, 
glabrous, white-buff fungal colonies grew after 30 days of 
incubation at 32°C. The colonies were transferred onto SDA, 
Czapek-Dox (HiMedia Laboratories Pvt, Mumbai, India) and 
potato dextrose agar and incubated at 28°C and 32°C. Flat white 
colonies grew very slowly at 32°C. Microscopic examination 
showed septate and gnarled hyphae. Subsequent subcultures 
were performed. Four months later, colonies became buff to 
light yellow (Fig. S2a1); the reverse was purplish. Microscopic 
features showed brown, short and smooth-walled conidiopho-
res, hemispherical vesicles with small metulae and phialides 
on the upper portion. Conidia were globose and rough; Hülle 
cells were abundant (Fig. S2b1). A. nidulans was suspected, and 
confirmed by growth at 37°C, performed in order to differen-
tiate it from A. versicolor. The identification was confirmed 
by DNA sequencing. Genomic DNA was extracted from a 
sporulating colony using PrepMan Ultra Sample PreparationTM 
reagent (Applied Biosystems, Waltham, MA, USA). A portion 
of the beta-tubulin gene was amplified using the primers TUBF 
(TGACCCAGCAGATGTT) and TUBR (GTTGTTGGGAATC-
CACTC). The PCR products (≈340 bp) were visualized on 
1.4% agarose gel stained with ethidium bromide and used as a 
template for DNA sequencing by means of Big Dye terminators 
(Applied Biosystems) in a 310 ABI PRISM sequencer (Applied 
Biosystems). Nucleotide sequences were analysed using Mo-
byle portal (http://mobyle.pasteur.fr/) and compared with the 
sequences present in GenBank. The sequence was deposited 
in Genbank with accession number KP233835.
In February 2013, the patient began therapy with oral fluco-
nazole (400 mg/day). Four months later, no improvement was 
observed. We therefore decided to use liposomal amphotericin 
B. However, the patient was lost to follow-up.
DISCUSSION
The genus Aspergillus is classified into 7 subgenera. 
The identification of A. nidulans (teleomorph Emeri-
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cella nidulans) is usually based on macro- and micro-
scopic morphology. Colonies on potato dextrose agar 
at 25°C are dark green, with an orange to yellow colour 
in areas of cleistothecial production. The reverse is 
purplish to olive in colour. The growth rate is slow, 
hyphae are septate and hyaline, conidial heads are 
columnar, and the conidiophores are brown, short and 
smooth-walled. The vesicles are hemispherical, small, 
with metulae and phialides on the upper portion. The 
conidia are globose and rough. E. nidulans produces 
brown-black globose cleistothecia, which are engulfed 
by Hülle cells. Ascospores are reddish-brown, lenti-
cular, with 2 longitudinal crests in comparison with 
other clinically significant Aspergillus species.
No reports of mycetoma due to A. nidulans were 
published from 1906 until 1968, when this fungus was 
isolated twice from a farmer in Senegal with mycetoma 
of a knee (1, 2). In 1971, Mahgoub (3) described a farmer 
from Sudan affected by a painless swelling on a sole, 
with many sinuses and bloody discharge. Some white-
yellowish grains, 1–2 mm in diameter, were observed. 
Histopathological examination revealed an abscess, with 
oval or round or bilobed grains and irregular oval or 
round pale spores. Specific antibodies against A. nidulans 
were detected. An additional case was reported by the 
same author (4): the patient was a Sudanese farmer with 
a swelling involving a thigh and knee, accompanied by 
severe pain. Sinuses discharging pus and white grains 
were observed. Histopathological examination revealed 
the presence of round, white grains, 1–2 mm in diameter, 
and highly segmented hyphae. Radiographs revealed 
fungal involvement of the heads of the tibia and fibula, 
cavitation in femur, patella periosteal bone deposition and 
diffuse osteoporosis. Finally, Joshi et al. (5) described an 
Indian farmer with a mycetoma of the neck characteri-
zed by many sinuses discharging blood. Round-to-oval, 
white-yellowish granules, 0.5–1 mm in diameter, were 
isolated. Mycological examinations showed pale spores, 
whitish filamentous and eosinophilic hyphae. No data 
were published on the therapy of all these patients. It 
is important to emphasize that, in all these cases, the 
diagnosis of mycetoma caused by A. nidulans was based 
only on the morphology of the colonies. Our case can 
therefore be considered as the first report of mycetoma 
caused by A. nidulans identified by means of a molecular 
study. The fact that A. nidulans can be a pathogenic 
agent is demonstrated by cases of osteomyelitis (6–10), 
pneumonia (6, 7, 9, 11, 13, 14) and skin abscess (14), 
reported especially in patients with chronic granuloma-
tous disease (6–10, 12–15). In these cases, amphotericin 
B (7, 8, 12–14), caspofungin (13, 14), flucytosine (7), 
itraconazole (8) and voriconazole (13, 14) were used, 
although with conflicting clinical results. 
A. nidulans must be considered as a potential patho-
genic agent in mycetoma. The final mycological diag-
nosis must be based on molecular identification.
The authors declare no conflicts of interest.
REFERENCES
1. Baylet R, Camain R, Chabal J, Izarn R. Recent contribution 
to the study of mycetoma in Senegal. Neotestudina rosatii, 
Pyrenochaeta romeroi, Aspergillus nidulans. Bull Soc Med 
Afr Noire Lang Fr 1968; 13: 311–313.
2. Baylet R, Lacoste L, Camain R, Basset A, Chabal J, Izarn 
R. Aspergillus nidulans, agent de mycétomes. Bull Soc 
Pathol Exot 1968; 61: 359–365.
3. Mahgoub ES. Maduromycetoma caused by Aspergillus 
nidulans. J Trop Med Hyg 1971; 74: 60–61.
4. Mahgoub ES. Mycetomas caused by Curvularia lunata, 
Madurella grisea, Aspergillus nidulans, and Nocardia bra-
siliensis in Sudan. Sabouraudia 1973; 11: 179–182.
5. Joshi KR, Mathur DR, Sharma JC, Vyas MCR, Sanghvi A. 
Mycetoma caused by Aspergillus nidulans in India. J Trop 
Med Hyg 1985; 88: 41–44.
6. Bujak JS, Kwon-Chung KJ, Chusid MJ. Osteomyelitis and 
pneumonia in a boy with chronic granulomatous disease of 
childhood caused by a mutant strain of Aspergillus nidulans. 
Am J Clin Pathol 1974; 61: 361–367.
7. White CJ, Kwon-Chung KJ, Gallin JI. Chronic granulo-
matous disease of childhood. An unusual case of infection 
with Aspergillus nidulans var. echinulatus. Am J Clin Pathol 
1988; 90: 312–316.
8. Dotis J, Panagopoulou P, Filioti J, Winn R, Toptsis C, Pan-
teliadis C, et al. Femoral osteomyelitis due to Aspergillus 
nidulans in a patient with chronic granulomatous disease. 
Infection 2003; 31: 121–124.
9. Dotis J, Roilides E. Osteomyelitis due to Aspergillus spp. in 
patients with chronic granulomatous disease: comparison of 
Aspergillus nidulans and Aspergillus fumigatus. Int J Infect 
Dis 2004; 8: 103–110.
10. Dotis J, Roilides E. Osteomyelitis due to Aspergillus species 
in chronic granulomatous disease: an update of the litera-
ture. Mycoses 2011; 54: e686–696.
11. Mizuki M, Chikuba K, Tanaka K. A case of chronic necro-
tizing pulmonary aspergillosis due to Aspergillus nidulans. 
Mycopathologia 1994; 128: 75–79.
12. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, 
Gallin JI, Holland SM. Aspergillus nidulans infection in 
chronic granulomatous disease. Medicine (Baltimore) 
1998; 77: 345–354.
13. Rösen-Wolff A, Koch A, Friedrich W, Hahn G, Gahr M, 
Roesler J. Successful elimination of an invasive Aspergillus 
nidulans lung infection by voriconazole after failure of a 
combination of caspofungin and liposomal amphotericin B 
in a boy with chronic granulomatous disease. Pediatr Infect 
Dis 2004; 23: 584–586.
14. Dellepiane RM, Tortorano AM, Liotto N, Laicini E, Di 
Landro G, Carnelli V et al. Invasive Aspergillus nidulans 
infection in a patient with chronic granulomatous disease. 
Mycoses 2008; 51: 458–460.
15. Henriet SSV, Verweij PE, Warris A. Aspergillus nidulans 
and chronic granulomatous disease: a unique host-pathogen 
interaction. J Infect Dis 2012: 206: 1128–1137.
Acta Derm Venereol 96
